Evidence map›Paper›PMID 37032391›Full record

ArticleBlood cancer journal2023

Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients.

Ahmad Alcheikh, Griffith B Perkins, Phillippa A Pucar, Amelia Cecchin, Cheng Sheng Chai, Matthew Tunbridge, Anouschka Akerman, Anupriya Aggarwal, Vanessa Milogiannakis, Stuart Turville and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. CD56Clinical & translational immunology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ahmad Alcheikh *Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia. a.alcheikh@gmail.com.ORCID 0000-0002-2616-7111
Griffith B Perkins *Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.ORCID 0000-0001-8559-5872
Phillippa A PucarImmunology Directorate, SA Pathology, Adelaide, Australia.
Amelia CecchinImmunology Directorate, SA Pathology, Adelaide, Australia.
Cheng Sheng ChaiAdelaide Medical School, University of Adelaide, Adelaide, Australia.
Matthew TunbridgeCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.
Anouschka AkermanKirby Institute, University of New South Wales, Sydney, Australia.
Anupriya AggarwalKirby Institute, University of New South Wales, Sydney, Australia.
Vanessa MilogiannakisKirby Institute, University of New South Wales, Sydney, Australia.
Stuart TurvilleKirby Institute, University of New South Wales, Sydney, Australia.
Sharon AllenDepartment of Haematology, Royal Adelaide Hospital, Adelaide, Australia.
Pravin HissariaCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.
Tatjana BanovicImmunology Directorate, SA Pathology, Adelaide, Australia.
P Toby CoatesCentral and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.
David M RossDepartment of Haematology, Royal Adelaide Hospital, Adelaide, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Primary MyelofibrosisHumansImmunity, CellularSARS-CoV-2Vaccination

Identifiers

PMID37032391
PMCPMC10083173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.